This topic contains a solution. Click here to go to the answer

Author Question: From first to last, name the eons on the Geologic Time Scale. A) Phanerozoic, Proterozoic, ... (Read 80 times)

lunatika

  • Hero Member
  • *****
  • Posts: 548
From first to last, name the eons on the Geologic Time Scale.
 
  A) Phanerozoic, Proterozoic, Archean, Hadean.
  B) Hadean, Archean, Proterozoic, Phanerozoic.
  C) Proterozoic, Phanerozoic, Hadean, Archean.
  D) Precambrian, Phanerozoic, Proterozoic, Paleozoic.

Question 2

Sea level fluctuated several times during the Paleozoic. Which of the following is not a representative factor for sea level rise in the Paleozoic?
 
  A) Melting of continental glaciers.
  B) Ocean basins stood high on the asthenosphere due to active seafloor spreading.
  C) Ocean basins stood high on the asthenosphere due to slow but continuous seafloor convergence.
  D) The breakup of the Precambrian supercontinent.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

rosiehomeworddo

  • Sr. Member
  • ****
  • Posts: 306
Answer to Question 1

Answer: B

Answer to Question 2

Answer: C





 

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library